Nvidia Invests in Generate Biomedicines, Aligning With CEO's Vision of AI Impact on Life Sciences
Nvidia has invested in biotech company Generate Biomedicines (NASDAQ: GENB), reflecting its commitment to leveraging artificial intelligence in life sciences. The investment aligns with Nvidia CEO Jensen Huang’s statement that AI will have the most profound impact in healthcare, particularly through collaborations like the $1 billion joint lab initiative with Eli Lilly.
Tickers: $CRWV $GENB $INTC $NVDA
Topics: AI biotech Generate Biomedicines healthcare Nvidia